回声与阴影：利用肺部超声和X光预测肝肾综合征的预后
Echoes and Shadows: Predicting Hepatorenal Syndrome Outcomes with Lung Ultrasound and X-rays.
作者信息
Kothekar Amol T, Shah Keyurkumar B
机构信息
Department of Anaesthesia, Critical Care and Pain, ACTREC Tata Memorial Center, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
Department of Anaesthesia, Critical Care and Pain, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
出版信息
Indian J Crit Care Med. 2024 Nov;28(11):993-994. doi: 10.5005/jp-journals-10071-24836. Epub 2024 Oct 30.
Abstract
Kothekar AT, Shah KB. Echoes and Shadows: Predicting Hepatorenal Syndrome Outcomes with Lung Ultrasound and X-rays. Indian J Crit Care Med 2024;28(11):993-994.
摘要
科特卡尔·A·T、沙阿·K·B。回声与阴影：用肺部超声和X线预测肝肾综合征的结局。《印度危重症医学杂志》2024年；28(11):993 - 994。
相似文献
1
Echoes and Shadows: Predicting Hepatorenal Syndrome Outcomes with Lung Ultrasound and X-rays.回声与阴影：利用肺部超声和X光预测肝肾综合征的预后
Indian J Crit Care Med. 2024 Nov;28(11):993-994. doi: 10.5005/jp-journals-10071-24836. Epub 2024 Oct 30.
2
Point-of-care Ultrasonography in Patients with Hepatorenal Syndrome: A Single Center Observational Study.肝肾综合征患者的床旁超声检查：一项单中心观察性研究
Indian J Crit Care Med. 2024 Nov;28(11):1015-1022. doi: 10.5005/jp-journals-10071-24827. Epub 2024 Oct 30.
3
Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis.失代偿期肝硬化患者肝肾综合征的治疗：一项网状Meta分析。
Cochrane Database Syst Rev. 2019 Sep 12;9(9):CD013103. doi: 10.1002/14651858.CD013103.pub2.
4
Evaluation of terlipressin-related patient outcomes in hepatorenal syndrome-acute kidney injury using point-of-care echocardiography.应用床旁超声心动图评估肝肾综合征-急性肾损伤患者特利加压素相关治疗结局。
Hepatology. 2024 May 1;79(5):1048-1064. doi: 10.1097/HEP.0000000000000691. Epub 2023 Nov 16.
5
Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome.特利加压素与安慰剂或不干预措施治疗肝硬化和肝肾综合征患者的比较
Cochrane Database Syst Rev. 2017 Jun 14;6(6):CD005162. doi: 10.1002/14651858.CD005162.pub4.
6
Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.特利加压素联合白蛋白与白蛋白治疗肝硬化合并肝肾综合征患者的随机研究
Gastroenterology. 2008 May;134(5):1352-9. doi: 10.1053/j.gastro.2008.02.024. Epub 2008 Feb 14.
7
Combined Cardiopulmonary Ultrasound: A Treatment Changing Modality in Acute Respiratory Failure.心肺联合超声：急性呼吸衰竭治疗方式的变革
Indian J Crit Care Med. 2020 Nov;24(11):1008-1009. doi: 10.5005/jp-journals-10071-23651.
8
Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome.特利加压素与白蛋白用于肝硬化合并I型肝肾综合征患者的治疗
Dig Dis Sci. 2008 Mar;53(3):830-5. doi: 10.1007/s10620-007-9919-9. Epub 2007 Oct 16.
9
Treatment-Related Cost Analysis of Terlipressin for Adults with Hepatorenal Syndrome with Rapid Reduction in Kidney Function.特利加压素治疗肾功能快速下降的肝肾综合征成人患者的相关治疗费用分析。
Adv Ther. 2023 Dec;40(12):5432-5446. doi: 10.1007/s12325-023-02674-z. Epub 2023 Oct 9.
10
A study on clinical outcomes of combination of terlipressin and albumin in Hepatorenal Syndrome.特利加压素联合白蛋白治疗肝肾综合征的临床疗效研究。
Scand J Gastroenterol. 2020 Jul;55(7):860-864. doi: 10.1080/00365521.2020.1786851. Epub 2020 Jul 7.
本文引用的文献
1
Point-of-care ultrasonography in cirrhosis-related acute kidney injury: How I do it.肝硬化相关性急性肾损伤的床旁超声检查：我的操作方法。
World J Crit Care Med. 2024 Jun 9;13(2):93812. doi: 10.5492/wjccm.v13.i2.93812.
2
Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting.肝硬化患者的急性肾损伤：急性疾病质量倡议 (ADQI) 和国际腹水俱乐部 (ICA) 联合多学科共识会议。
J Hepatol. 2024 Jul;81(1):163-183. doi: 10.1016/j.jhep.2024.03.031. Epub 2024 Mar 26.
3
Evaluation of terlipressin-related patient outcomes in hepatorenal syndrome-acute kidney injury using point-of-care echocardiography.应用床旁超声心动图评估肝肾综合征-急性肾损伤患者特利加压素相关治疗结局。
Hepatology. 2024 May 1;79(5):1048-1064. doi: 10.1097/HEP.0000000000000691. Epub 2023 Nov 16.
4
Incidence and outcomes of acute kidney injury including hepatorenal syndrome in hospitalized patients with cirrhosis in the US.美国住院肝硬化患者急性肾损伤（包括肝肾综合征）的发生率和结局。
J Hepatol. 2023 Dec;79(6):1408-1417. doi: 10.1016/j.jhep.2023.07.010. Epub 2023 Jul 28.
5
Acute Kidney Injury in Patients with Cirrhosis.肝硬化患者的急性肾损伤
N Engl J Med. 2023 Feb 23;388(8):733-745. doi: 10.1056/NEJMra2215289.
6
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.特利加压素联合白蛋白治疗 1 型肝肾综合征。
N Engl J Med. 2021 Mar 4;384(9):818-828. doi: 10.1056/NEJMoa2008290.
7
News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus document.肝性肾病综合征的病理生理学、定义和分类的新进展：超越国际腹水俱乐部（ICA）共识文件的一步。
J Hepatol. 2019 Oct;71(4):811-822. doi: 10.1016/j.jhep.2019.07.002. Epub 2019 Jul 11.
8
Cirrhotic cardiomyopathy.肝硬化性心肌病。
J Hepatol. 2010 Jul;53(1):179-90. doi: 10.1016/j.jhep.2010.02.023. Epub 2010 Mar 31.
9
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.肝硬化难治性腹水和肝肾综合征的定义及诊断标准。国际腹水俱乐部。
Hepatology. 1996 Jan;23(1):164-76. doi: 10.1002/hep.510230122.
Zotero 插件